Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal–Organic Framework Nanoparticles to Boost Cancer Immunotherapy-Reference-Cited by-同舟云学术

Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal–Organic Framework Nanoparticles to Boost Cancer Immunotherapy

Published:2019-11-20 Issue:1 Volume:9 Page:1900996
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Cai Zhixiong¹^ORCID,Xin Fuli²³^ORCID,Wei Zuwu²³^ORCID,Wu Ming²³^ORCID,Lin Xinyi¹^ORCID,Du Xiaofan¹^ORCID,Chen Geng¹^ORCID,Zhang Da²³^ORCID,Zhang Zhenxi¹^ORCID,Liu Xiaolong²³^ORCID,Yao Cuiping¹^ORCID

Affiliation:

1. Key Laboratory of Biomedical Information Engineering of Ministry of EducationInstitute of Biomedical Analytical Technology and InstrumentationSchool of Life Science and TechnologyXi'an Jiaotong University Xi'an 710049 P. R. China

2. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian ProvinceMengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou 350025 P. R. China

3. The Liver Center of Fujian ProvinceFujian Medical University Fuzhou 350025 P. R. China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.201900996

Reference41 articles.

1. Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons